NPPA: Ceiling price of scheduled formulations revised

The NPPA has revised/ increased the ceiling price of 883 scheduled formulations in compliance of the provisions of Drugs (Price Control) Order 2013.

The Authority conducted a meeting on 31.03.2020 noted with satisfaction that the supply disruption of APIs caused by COVID-19 outbreak is returning to normalcy and no unusual price fluctuations in price of inputs for medicines, amid COVID-19 outbreak has been reported. Thus, normal price revisions have been allowed.

The Wholesale Price Index increase has been based on the data published by Department for Promotion of Industry and Internal Trade, Ministry of Commerce and Industry, Government of India. Increase in ceiling price is based on Wholesale Price Index (WPI) is 1.88468 percent.

The revision in ceiling price of formulations also includes the revision of ceiling price of cardiac stents also.

The revised prices will be applicable from 1st April 2020 and the detail of revised prices is available on NPPA’s website

  • Related Posts

    Meanness Thy Name is Donald Trump making Medicines cost a Bomb

    Don’t please treat Health as a Trade War Pawn- Dr Aashish Chaudhry New Delhi: Donald Trump has not covered himself with glory by imposing 100 percent tariffs on pharmaceutical imports.…

    MNCs seek restart of refurbished medical device imports

    New Delhi, August 19, 2025 — Global med-tech companies have urged the Centre to allow refurbished medical device imports again and include medical devices in India’s repair-services push. The request…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

    Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

    Ayurveda practitioner fined by ISM Council for violation of professional ethics

    Ayurveda practitioner fined by ISM Council for violation of professional ethics

    Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

    Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

    Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

    Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

    DoP may exempt 11 more drugs from public procurement rules

    DoP may exempt 11 more drugs from public procurement rules

    DoP calls for proposals to set up common facilities for medical device clusters

    DoP calls for proposals to set up common facilities for medical device clusters